Diligence memo · auto-generated · as of July 3, 2026
Spinnaker Biosciences, Inc.
Spinnaker Biosciences, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Spinnaker Biosciences, Inc. operates in Biotech / Pharma, based in SOLANA BEACH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Spinnaker Biosciences, Inc. has raised $2.6M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $1.0M on 2010-12-01.
Most recent recorded round closed around 2024-11-26.
Valuation (modeled)modeled
Provath models Spinnaker Biosciences, Inc. at approximately $2.4M (range $365K–$7.1M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.13× the median modeled value of Pre-Seed Biotech / Pharma companies in 2022–2024 (28 peers) — value vs value, same stage and era. Within the normal band (113% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 84 months.
Last raise 19 mo ago; this sector typically re-raises about every 15 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 41% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 17% of those peers.
Closest niche peers: Gaingels Oct Bio LLC, Gaingels Alto Pharmacy LLC, Pyros Pharmaceuticals, Inc., Allander Biotechnologies, Inc., CyMon Bio, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.